British American Tobacco (BAT), the world’s second‑largest tobacco company by market value, announced on Tuesday that it expects revenue from its smoking‑alternative portfolio – including e‑cigarettes, vape devices and nicotine pouches – to grow at a mid‑teens percentage rate each year through 2030. The guidance was delivered ahead of an investor‑day event where the firm will outline its full‑decade growth strategy.
Revenue outlook and profit margin targets
BAT said the contribution margin – a measure of profitability – for its alternative‑nicotine products is projected to reach at least 30% by 2030, up from 13.3% in June 2026. The company reiterated its earlier forecast of mid‑teens revenue growth for 2026 and confirmed that the same growth trajectory will continue in the years that follow.
Why alternatives matter for BAT
Traditional cigarette sales have been in long‑term decline in several key markets, prompting BAT to diversify its product mix. The firm highlighted the rapid expansion of its nicotine‑pouch brand Velo, which has helped offset slower growth in its vape and heated‑tobacco lines. By focusing on products that deliver nicotine without combustion, BAT aims to capture consumers who are moving away from conventional cigarettes.
Financial guidance for 2026
In addition to its alternative‑nicotine outlook, BAT confirmed that it remains on track to meet the lower end of its guidance for overall revenue growth of 3% to 5% for the 2026 financial year. Adjusted profit from operations is also expected to grow between 4% and 6% during the same period.
Investor‑day preview
The upcoming investor day will provide more detail on how BAT plans to execute its growth strategy, including product development, market expansion and cost‑efficiency initiatives. Analysts will be watching closely for updates on the company’s approach to regulation, especially as governments worldwide consider stricter rules for vaping and nicotine‑pouch products.
Industry context
The broader tobacco sector is seeing a shift toward reduced‑risk products. Competitors are also investing heavily in e‑cigarettes and nicotine pouches, creating a competitive environment that rewards innovation and strong margins. BAT’s confidence in achieving a 30% contribution margin reflects its belief that it can lead the market in delivering profitable, lower‑risk alternatives.
What this means for consumers
For smokers looking for alternatives, BAT’s expanding portfolio suggests more product choices and potentially greater availability of vaping devices and nicotine pouches in the coming years. The company’s focus on profitability also indicates a commitment to sustaining these products in the market, rather than treating them as a short‑term experiment.
Looking ahead
While regulatory scrutiny remains a factor, BAT’s forward‑looking statements signal confidence that smoking‑alternative products will continue to grow both in sales volume and profitability. The investor‑day presentation later this week should shed light on how the company plans to navigate regulatory challenges while delivering on its ambitious growth targets.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
